Literature DB >> 28626173

Prevalence of Right to Left Shunts in Japanese Patients with Migraine: A Single-center Study.

Akio Iwasaki1, Keisuke Suzuki2, Hidehiro Takekawa1,3, Ryotaro Takashima2, Ayano Suzuki1, Shiho Suzuki2, Koichi Hirata2.   

Abstract

Objective Several studies have shown an increased prevalence of right-to-left shunt (RLs) in migraine patients, particularly those with aura. However, the prevalence of RLs and its relation to Japanese patients with migraine are unknown. We investigated the prevalence of RLs in Japanese patients with migraine. Methods In total, 112 consecutive patients with migraine were recruited from our headache outpatient clinic. Migraine with aura (MA) and migraine without aura (MWOA) were diagnosed according to the International Classification of Headache Disorders, 3rd edition (beta-version). Contrast transcranial Doppler ultrasound was used to detect RLs, including patent foramen ovale (PFO). Then, the associations between RLs and patients' backgrounds and presence of aura were assessed. Results The overall prevalence of RLs and PFO in migraine patients was 54.5% and 43.8%, respectively. The prevalence of RLs and PFO in the MA group were significantly higher than in the MWOA group (RLs, 62.9% vs. 44.0%, p=0.046; PFO, 54.8% vs. 30.0%, p=0.008). There were no marked differences in the prevalence of large, middle and small shunts between MA and MWOA patients. Compared with the MWOA patients, the MA patients were younger (p=0.013) and had early onset age (p=0.013) and increased prevalence of photophobia (p=0.008). Conclusion RLs were found in over half of the Japanese patients with migraine. Our study suggests a possible link between RLs and MA.

Entities:  

Keywords:  migraine; migraine with aura; patent foramen ovale; pulmonary arteriovenous malformation; right-to-left shunt; transcranial ultrasonography

Mesh:

Year:  2017        PMID: 28626173      PMCID: PMC5505903          DOI: 10.2169/internalmedicine.56.8099

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Patent foramen ovale (PFO) is a condition in which the foramen ovale, which normally closes at birth due to the elevation in the left atrial pressure during the transition to pulmonary circulation, is left unclosed (1). It has been reported that 15-35% of healthy people have PFO (2,3). PFO causes the formation of right-to-left shunts (RLs) during the Valsalva maneuver or at rest. Although several diseases, such as arteriovenous malformation (AVM) or atrial septum deficits, can cause RLs, PFO is the most common underlying factor for RLs (4). A relationship between PFO and migraine has been reported. One hypothesis is that the passage of metabolic substances or subclinical emboli through a PFO stimulates the trigeminal nerve and cerebrovascular system, evoking migraine-like headaches (5). Although several studies reported no relationship between migraine and PFO (5), 40-70% of patients with migraine with aura (MA) have been reported to have PFO (6). Additionally, an increased prevalence of PFO has been described in patients with chronic migraine compared to the general population and other headache groups (7). An increased prevalence of RLs has been found in patients with migraine, especially those with MA, in several cross-sectional studies; however, this relationship has not been replicated in population-based studies (8,9) and the association between migraine and RLs has not been well studied in Asian populations. We conducted a single-center, cross-sectional study consisting of consecutive migraine patients from a headache outpatient clinic to explore the prevalence of RLs and its associated features in Japanese patients with migraine and to test our hypothesis that patients with migraine with aura are associated with the presence of RLs.

Materials and Methods

Between April 2014 and May 2016, 119 consecutive migraine patients (mean age 39.8±13.0 years, 7 men and 112 women) were recruited from our headache outpatient clinic at the Department of Neurology of Dokkyo Medical University Hospital. Seven patients were excluded from the study: six because of a loss in permeability during transcranial Doppler (TCD) evaluation of temporal bones and one due to insufficient information about migraine. Ultimately, 112 patients (mean age 38.6±12.2 years, 6 men and 106 women) were included in our study. MA and migraine without aura (MWOA) were diagnosed by headache specialists (RT, SS and KH) in accordance with the International Classification of Headache Disorders 3rd edition (beta-version) (10). Clinical information, including smoking status and onset age of migraine; family history of migraine; sensitivity to light, sound or smell; and comorbid diseases such as hypertension, dyslipidemia and diabetes mellitus, was obtained by questioning the patients. The clinical characteristics and prevalences of RLs were compared between the MA and MWOA groups. The institutional review board of Dokkyo Medical University Hospital approved the study (IRB approved number: 25028). All of the patients provided their written informed consent to participate.

Diagnosis of right-to-left shunts

RLs was assessed in all the patients by transcranial Doppler ultrasound (TCD; Pioneer TC8080 System; Nicolet Vascular, Tokyo, Japan) with intravenous injection of agitated saline with microbubbles by trained neurologists (AI, HT and AS). The M1 portion of the right middle cerebral artery (MCA) was depicted using a 2-MHz probe securely fixed by a headband through a gap in the temporal bone window. High-intensity transient signals (HITSs) were defined as strong transient signals (within 100 msec duration) that appeared in the same direction as the blood flow, with the intensity being at least 3-dB higher than the background reflecting the blood stream, in accordance with the criteria proposed by national consensus (11,12). The sampling volume was set to within 8 to 10 mm, and the depth was set to between 50 and 55 mm. At first, prior to the intravenous injection of contrast agent, simple observation was performed for 20 minutes. The HITS detection threshold volume was set to >6 dB. Then, 10 mL of contrast agent (a mixture of 9 mL saline and 1 mL air) was injected intravenously during the Valsalva maneuver. If HITSs were detected within 10 seconds after Valsalva load release, PFO was diagnosed. Next, careful observation was made to detect HITS for 3 minutes after Valsalva load release. If HITSs were detected within 3 minutes, additional observation was made for 3 minutes. Contrast agent was then injected intravenously without the Valsalva maneuver, and we continued observation for another 3 minutes. If HITSs were detected without Valsalva load, PFO or pulmonary AVM (pAVM) was diagnosed (13). Large shunts were defined as >26 HITSs, and middle shunts were defined as 5-26 HITSs. The same procedure was repeated 3 times for all patients (Fig. 1).
Figure 1.

Flowchart for the diagnosis of right-to-left shunts. RLs: right-to-left shunts, TCD: transcranial Doppler, HITS: high-intensity transient signals, PFO: patent foramen ovale

Flowchart for the diagnosis of right-to-left shunts. RLs: right-to-left shunts, TCD: transcranial Doppler, HITS: high-intensity transient signals, PFO: patent foramen ovale

Statistical analyses

All data are described as proportions (%) and medians (range) or means (± standard deviation). The patients were classified into the MA or MWOA groups based on the presence of aura. Univariate analyses were conducted to compare the characteristics between the two groups. The chi-square test and Mann-Whitney U test were used to compare the characteristics between the MA and MWOA groups. All p values were two-tailed, and p values <0.05 were considered significant. All statistical analyses were performed using the IBM SPSSⓇ software program for Mac, ver. 23 (Tokyo, Japan).

Results

Detection of RLs

A total of 112 subjects (106 women, median age, 39.0 years, range 14-74 years) underwent the TCD examination. On simple observation, prior to intravenous injection, HITSs were not detected in any patients. Next, during a 3-minute observation period after contrast agent injection with the Valsalva maneuver, HITSs were detected in 61 subjects (54.5%). With contrast agent administration at rest, HITSs were detected in 12 subjects (10.7%). Based on these results, a total of 49 subjects (43.8%) were diagnosed with PFO, and 12 subjects (10.7%) were diagnosed with PFO or pAVM (Fig. 1). The maximum numbers of HITSs per examination were as follows: 1-5 HITSs, 40 subjects; 5-26 HITSs, 7 subjects; >26 HITSs, 14 subjects.

Comparison between MA and MWOA

Among the 112 patients with migraine, 62 had MA and 50 had MWOA. The median ages of the MA and MWOA groups were 37.5 and 40.5 years old. The MA group was significantly younger than the MWOA group (p=0.013). Similarly, the onset age was also younger in the MA patients than in the MWOA patients (p=0.013). Among the total cohort, 74 subjects (66.1%) had a family history of migraine. Photophobia (75.9%), phonophobia (74.1%), and hypersensitivity to smell (56.3%) were commonly observed. Photophobia was more frequent in the MA group than in the MWOA group (86.2% vs. 64.0%, p=0.008). However, there was no significant difference in the prevalence of phonophobia, hypersensitivity to smell, altered taste, or allodynia between the MA and MWOA groups (Table 1).
Table 1.

Patient Characteristics between Migraine with and without Aura.

CharacteristicsTotal (n=112)MA (n=62)MWOA (n=50)p value
Age, median (range) years39.0 (14-74)37.5 (16-74)40.5 (14-71)0.013
Sex, male, n (%)6 (5.40)4 (6.2)2 (4.0)0.567
Hypertension, n (%)8 (7.10)3 (4.6)5 (10.0)0.292
Diabetes mellitus, n (%)3 (2.70)2 (3.1)1 (2.0)0.690
Dyslipidemia, n (%)12 (10.7)4 (6.2)8 (16.0)0.104
Family history of migraine, n (%)74 (66.1)41 (63.1)34 (68.0)0.699
Photophobia, n (%)85 (75.9)56 (86.2)32 (64.0)0.008
Phonophobia, n (%)83 (74.1)55 (84.6)36 (72.0)0.648
Hypersensitivity to smell, n (%)63 (56.3)34 (52.3)26 (52.0)0.416
Altered taste, n (%)11 (9.80)7 (10.8)4 (8.0)0.561
Allodynia, n (%)7 (6.30)5 (8.10)2 (4.0)0.377
Onset age of migraine, Median (range) years18.0 (9-40)16.0 (9-37)20.0 (9-40)0.013
Disease duration, Median (range) years19.0 (0-52)17.0 (0-52)20.5 (0-51)0.197

MA: migraine with aura, MWOA: migraine without aura, RLs: right to left shunts

Chi-square test and Mann-Whitney U test

Patient Characteristics between Migraine with and without Aura. MA: migraine with aura, MWOA: migraine without aura, RLs: right to left shunts Chi-square test and Mann-Whitney U test The prevalence of RLs was significantly higher in the MA group (62.9%) than in the MWOA group (44.0%) (p=0.046) (Fig. 2). In addition, a higher prevalence of PFO was observed in the MA group than in the MWOA group (54.8% vs. 30.0%, p=0.008) (Table 2). Concerning the shunt sizes, there were no differences in the prevalence of large, middle, and small shunts between MA and MWOA patients.
Figure 2.

Prevalence of RLs in the MWOA and MWA groups. MA: migraine with aura, MWOA: migraine without aura, RLs: right-to-left shunts. Chi-square test.

Table 2.

Prevalence of RLs between Migraine with and without Aura.

CharacteristicsTotal (n=112)MA (n=62)MWOA (n=50)p value
RLs positive, n (%)61 (54.5)39 (62.9)22 (44.0)0.046
PFO, n (%)49 (43.8)34 (54.8)15 (30.0)0.008
PFO or pulmonary arteriovenous malformations suspected, n (%)12 (10.7)5 (8.1)7 (14.0)0.313
Large shunt, n (%)14 (12.5)10 (16.1)4 (8.0)0.196
Medium shunt, n (%)7 (6.3)4 (6.5)3 (6.0)0.922
Small shunt, n (%)40 (35.7)25 (40.3)15 (30.0)0.257

MA: migraine with aura, MWOA: migraine without aura, RLs: right to left shunts

Chi-square test and Mann-Whitney U test

Prevalence of RLs in the MWOA and MWA groups. MA: migraine with aura, MWOA: migraine without aura, RLs: right-to-left shunts. Chi-square test. Prevalence of RLs between Migraine with and without Aura. MA: migraine with aura, MWOA: migraine without aura, RLs: right to left shunts Chi-square test and Mann-Whitney U test

Discussion

In our study, we investigated the prevalence of RLs and its relationship with clinical background factors, including type of migraine. A main finding from our study is that a high prevalence of RLs (54.5%), especially in patients with aura (62.9%), was observed among Japanese patients with migraine, which is comparable to that reported in European studies (5,6). PFO is a well-known cause of paradoxical embolism (1), and the prevalence of PFO in healthy people ranges from 15% to 35% (2,3,14). Patients with migraine, particularly those with MA, have been reported to have an increased prevalence of PFO compared to individuals without migraine (6,15,16). A recent meta-analysis showed that PFO is associated with 2.5-fold total migraine and 3.4-fold MWA prevalence, but not with MWOA prevalence (17). In our study, we confirmed increased the prevalence of PFO in the MA group compared with the MWOA group (62.9% vs. 44.0%, p=0.046), in line with the results of previous studies (15,17). Increased prevalence of photophobia in MA patients compared with MWOA patients was observed in our study, which is in agreement with the findings from a study of 5,758 adult residents in Japan (18) that showed a photophobia rate of 43.9% and 17.9% in Japanese patients with MA and MWOA, respectively. The prevalence of RLs and PFO was significantly increased in the MA group compared with the MWOA group. However, there was no marked difference in the shunt sizes between the groups in our study. Schwerzmann et al. (19) reported increased rates of moderate or large shunts in the migraine group compared with control groups. Contrary to our report, Yang et al. (20) showed increased rates of total and large RLs but not small RLs in patients with MA compared with MWOA. As for intrapulmonary RLs, van Gent et al. (21) reported the increased prevalence of large shunts in MA patients compared with MWOA patients. These differences might be due to discrepancies in methodologies or populations. Regarding the mechanism underlying the potential relationship between PFO and migraine, PFO may allow vasoactive chemicals, such as serotonin and endothelin, or embolic material to bypass the pulmonary filter and reach the cerebral circulation to induce a migraine attack (15,22). Additionally, paradoxical air microemboli through the PFO may induce cerebral electrical activity, triggering migraine attacks (23). The effect of PFO closure on migraine has also been controversial. In several studies, PFO closure has successfully reduced the intensity and severity of migraine attacks (24), while in a double-blind randomized study that included with migraine, PFO closure failed to reduce migraine intensity and severity (9). Further discussions are needed in this point. Several limitations associated with the present study warrant mention. First, this study used a cross-sectional design, and healthy controls were not included. According to previous studies, 15-35% of healthy Caucasian and African-descent subjects have PFO (2,3). To our knowledge, there has been no clinical study evaluating the PFO prevalence in healthy Japanese subjects. One autopsy study showed the PFO prevalence to be 13.6% in 109 Japanese adults (mean age 69 years) and even lower (7.0%) in those ≤59 years of age (25). Second, not all patients with migraine who were seen in our hospital underwent a TCD examination; therefore, selection bias might have affected the study's results. The male:female ratio is lower in our study (1:16) than in a population-based study of migraine patients in Japan (1:3.6) (26). Third, MA patients were younger and had earlier migraine onset MWOA patients. Although the prevalence of PFO decreases with age (14), given that the age gap between the MA and MWOA groups was only three years, we believe the influence of age difference had little impact on the RLs prevalence.

Conclusion

RLs were found in over half of a cohort of Japanese patients with migraine. Our study suggests a possible link between RLs and MA in Japanese.

The authors state that they have no Conflict of Interest (COI).
  25 in total

Review 1.  Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography.

Authors:  M Jauss; E Zanette
Journal:  Cerebrovasc Dis       Date:  2000 Nov-Dec       Impact factor: 2.762

2.  Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.

Authors:  Gianluca Rigatelli; Fabio Dell'Avvocata; Federico Ronco; Paolo Cardaioli; Massimo Giordan; Gabriele Braggion; Silvio Aggio; Mauro Chinaglia; Giorgio Rigatelli; Jack P Chen
Journal:  JACC Cardiovasc Interv       Date:  2010-03       Impact factor: 11.195

3.  Prevalence of Patent Foramen Ovale in the Japanese Population- Autopsy Study.

Authors:  Junko Kuramoto; Akio Kawamura; Tomohisa Dembo; Tokuhiro Kimura; Keiichi Fukuda; Yasunori Okada
Journal:  Circ J       Date:  2015-06-18       Impact factor: 2.993

4.  Prevalence and size of directly detected patent foramen ovale in migraine with aura.

Authors:  M Schwerzmann; K Nedeltchev; F Lagger; H P Mattle; S Windecker; B Meier; C Seiler
Journal:  Neurology       Date:  2005-09-07       Impact factor: 9.910

5.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study.

Authors:  G P Anzola; M Magoni; M Guindani; L Rozzini; G Dalla Volta
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

6.  Relation between migraine and size of echocardiographic intrapulmonary right-to-left shunt.

Authors:  Marco W F van Gent; Johannes J Mager; Repke J Snijder; Cornelis J J Westermann; Herbert W M Plokker; Wouter J Schonewille; Vincent Thijs; Martijn C Post
Journal:  Am J Cardiol       Date:  2011-03-02       Impact factor: 2.778

Review 7.  Patent Foramen Ovale and Migraine: Closing the Debate--A Review.

Authors:  Nauman Tariq; Stewart J Tepper; Jennifer S Kriegler
Journal:  Headache       Date:  2016-03-07       Impact factor: 5.887

8.  Right-to-left shunt is common in chronic migraine.

Authors:  S J Nahas; W B Young; R Terry; A Kim; T Van Dell; A J Guarino; S D Silberstein
Journal:  Cephalalgia       Date:  2010-02-11       Impact factor: 6.292

9.  A meta-analysis of case-control studies of the association of migraine and patent foramen ovale.

Authors:  Hisato Takagi; Takuya Umemoto
Journal:  J Cardiol       Date:  2015-10-31       Impact factor: 3.159

10.  Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype.

Authors:  Giorgio Dalla Volta; Massimiliano Guindani; Paola Zavarise; Simona Griffini; Alessandro Pezzini; Alessandro Padovani
Journal:  J Headache Pain       Date:  2005-09       Impact factor: 7.277

View more
  1 in total

1.  The Value of Contrast-Enhanced Transesophageal Echocardiography in the Detection of Cardiac Right-to-Left Shunt Related with Cryptogenic Stroke and Migraine.

Authors:  Huiqin Zhang; Wenyan Huang; Tingyu Lan; Meng Zhang; Jing Yang; Hongxia Zhang; Lijuan Du
Journal:  Biomed Res Int       Date:  2020-12-12       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.